715 FS118, a tetravalent bispecific antibody targeting LAG-3 and PD-L1, induces LAG-3 shedding resulting in receptor downregulation by T cells via a novel mechanism of action

Ngā tūemi rite

• 715 FS118, a tetravalent bispecific antibody targeting LAG-3 and PD-L1, induces LAG-3 shedding resulting in receptor downregulation by T cells via a novel mechanism of action
  mā: Michelle Morrow, me ētahi atu.
  I whakaputaina: (2020-11-01)
• Bispecific antibodies targeting immunomodulatory checkpoints for cancer therapy
  mā: Tiancheng Zhang, me ētahi atu.
  I whakaputaina: (2023-03-01)
• Retention of the Bub3 checkpoint protein on lagging chromosomes
  mā: Martinez-Exposito, Maria J., me ētahi atu.
  I whakaputaina: (1999)
• PD-L1/LAG-3 bispecific antibody enhances tumor-specific immunity
  mā: Haiping Jiang, me ētahi atu.
  I whakaputaina: (2021-01-01)
• 1187 Antibody-lectin bispecifics for glyco-immune checkpoint blockade
  mā: Nicholas Riley, me ētahi atu.
  I whakaputaina: (2023-11-01)